Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04200365
Recruitment Status : Recruiting
First Posted : December 16, 2019
Last Update Posted : December 29, 2021
Incyte Corporation
Information provided by (Responsible Party):
SCRI Development Innovations, LLC

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2024
Estimated Study Completion Date : June 2024